These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17131691)

  • 1. [Prevention of atherothrombosis with low doses of acetylsalicylic acid].
    Ziegler R
    Med Monatsschr Pharm; 2006 Nov; 29(11):420-1. PubMed ID: 17131691
    [No Abstract]   [Full Text] [Related]  

  • 2. New guidelines refine aspirin prescription. Task force offers recommendation for women and guidance on dosage.
    Harv Heart Lett; 2009 Jun; 19(10):4-5. PubMed ID: 19681207
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-dose aspirin for the prevention of atherothrombosis.
    Patrono C; García Rodríguez LA; Landolfi R; Baigent C
    N Engl J Med; 2005 Dec; 353(22):2373-83. PubMed ID: 16319386
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetylsalicylic acid and vitamin E in prevention of arterial thrombosis.
    Polasek J
    Can J Cardiol; 1997 May; 13(5):533-5. PubMed ID: 9179093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis, causes, relevance of a complex phenomenon. Resistance to aspirin and clopidogrel].
    Mani H; Lindhoff-Last E
    Pharm Unserer Zeit; 2009; 38(4):342-50. PubMed ID: 19572355
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thrombosis from prosthetic materials: prevention with different antiaggregatory agents. Low dose aspirin?].
    Escudero MC; Alvarez L; Rodríguez V; de Haro J; Millán I; Torres MT; Jorge E; Castillo-Olivares JL
    Rev Esp Cardiol; 1990; 43(6):385-91. PubMed ID: 2146720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Do all the patients with adult-onset diabetes mellitus need acetylsalicylic acid?].
    Lassila R
    Duodecim; 1999; 115(10):1174-7. PubMed ID: 11877857
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin for primary prevention. Treatment policy should be based on all trial evidence, not subgroup analysis.
    Ramsay LE; Sanmuganathan PS; Wallis EJ; Jackson PR
    BMJ; 2000 Dec; 321(7274):1472. PubMed ID: 11187950
    [No Abstract]   [Full Text] [Related]  

  • 9. [Platelet function inhibitors as a way of arterial thrombosis prevention in the diabetic].
    Lecompte T
    Journ Annu Diabetol Hotel Dieu; 2001; ():197-220. PubMed ID: 11565463
    [No Abstract]   [Full Text] [Related]  

  • 10. Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology.
    Kuliczkowski W; Witkowski A; Polonski L; Watala C; Filipiak K; Budaj A; Golanski J; Sitkiewicz D; Pregowski J; Gorski J; Zembala M; Opolski G; Huber K; Arnesen H; Kristensen SD; De Caterina R
    Eur Heart J; 2009 Feb; 30(4):426-35. PubMed ID: 19174428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable platelet response to aspirin in patients with ischemic stroke.
    Hohlfeld T; Weber AA; Junghans U; Schumacher M; Boucher M; Schrör K; Siebler M
    Cerebrovasc Dis; 2007; 24(1):43-50. PubMed ID: 17519543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet agents and arterial thrombosis.
    Billett HH
    Cardiol Clin; 2008 May; 26(2):189-201, vi. PubMed ID: 18406994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of venous thrombosis with antiplatelet agents].
    Boneu B
    Ann Fr Anesth Reanim; 1992; 11(3):329. PubMed ID: 1503312
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-dose aspirin in polycythemia vera.
    Denes AE
    N Engl J Med; 2004 Apr; 350(16):1683-5; author reply 1683-5. PubMed ID: 15088323
    [No Abstract]   [Full Text] [Related]  

  • 15. Low-dose aspirin in polycythemia vera.
    Dutrillaux F; Maynadié M; Carli PM
    N Engl J Med; 2004 Apr; 350(16):1683-5; author reply 1683-5. PubMed ID: 15088322
    [No Abstract]   [Full Text] [Related]  

  • 16. Why aspirin cannot prevent arterial thrombosis.
    Altman R; Scazziota A
    Circulation; 1996 Dec; 94(11):3002-3. PubMed ID: 8941147
    [No Abstract]   [Full Text] [Related]  

  • 17. The C50T polymorphism of the cyclooxygenase-1 gene and the risk of thrombotic events during low-dose therapy with acetyl salicylic acid.
    Clappers N; van Oijen MG; Sundaresan S; Brouwer MA; Te Morsche RH; Keuper W; Peters WH; Drenth JP; Verheugt FW
    Thromb Haemost; 2008 Jul; 100(1):70-5. PubMed ID: 18612540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Withdrawing the use of acetylsalicyclic acid prior to an operation usually not necessary].
    van den Broek JA; van Duijnhoven JL
    Ned Tijdschr Geneeskd; 2003 Mar; 147(10):469; author reply 469. PubMed ID: 12666521
    [No Abstract]   [Full Text] [Related]  

  • 19. Pericardial hemorrhage due to acetylsalicylic acid in a patient with essential thrombocythemia.
    Kayrak M; Acar K; Yazici M; Kaya C; Ayhan SS; Gok H
    Clin Appl Thromb Hemost; 2009; 15(4):465-6. PubMed ID: 18160579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".
    Santilli F; Rocca B; De Cristofaro R; Lattanzio S; Pietrangelo L; Habib A; Pettinella C; Recchiuti A; Ferrante E; Ciabattoni G; Davì G; Patrono C
    J Am Coll Cardiol; 2009 Feb; 53(8):667-77. PubMed ID: 19232899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.